Pathology of preinvasive and excellent-prognosis breast cancer.
Concern about the recognition of especially good prognoses continues to be resolute among those who decide, with patients, the course of treatment. Prognostic considerations are paramount in this planning process, and should emphasize precision in case definition and repeated verification in comparable studies. Excellent-prognosis invasive lesions, subtyping of ductal carcinomas in situ, and premalignant indications within otherwise benign breast biopsy specimens are highlighted in this review.